CGTX insider buying and SEC filings, explained
Cognition Therapeutics Inc. · CIK 1455365
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$32K
Insiders who bought
3
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Apr 16, 2026 | Purchase (code P) | John Brendan Doyle (CFO) bought 10,000 shares at $1.13 ($11K), reported as a purchase (code P). Holdings up 2% to 627,509 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 20, 2026 |
| Apr 16, 2026 | Purchase (code P) | Lisa Ricciardi (CEO and Director) bought 9,175 shares at $1.10 ($10K), reported as a purchase (code P). Holdings up 1% to 1,715,851 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 20, 2026 |
| Apr 16, 2026 | Purchase (code P) | Anthony Caggiano (Chief Medical Officer) bought 10,000 shares at $1.11 ($11K), reported as a purchase (code P). Holdings up 1% to 874,906 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 20, 2026 |
15 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
3 insiders bought in 30 days
$32K in purchases since Apr 16, 2026 · Purchases traded Apr 16, 2026 to Apr 16, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Anthony Caggiano (Chief Medical Officer) | $11K | Apr 16, 2026 | SEC filing |
| Lisa Ricciardi (CEO) | $10K | Apr 16, 2026 | SEC filing |
| John Brendan Doyle (CFO) | $11K | Apr 16, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CGTX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.